BioGaia AB ser. B (0GTN)

103.00
-412.50(-80.02%)
  • Volume:
    93
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    103.00 - 103.00

0GTN Overview

Prev. Close
515.5
Day's Range
103-103
Revenue
1.1B
Open
101.19
52 wk Range
69-113.16
EPS
3.7
Volume
93
Market Cap
10.3B
Dividend (Yield)
3.63
(0.74%)
Average Volume (3m)
3,604
P/E Ratio
27.35
Beta
0.632
1-Year Change
-
Shares Outstanding
100,982,310
Next Earnings Date
04 May 2023
What is your sentiment on BioGaia B?
or
Vote to see community's results!

BioGaia AB ser. B Company Profile

BioGaia AB ser. B Company Profile

Industry
-
Sector
-
Employees
195
Market
Sweden

BioGaia AB (publ) develops, markets, and sells probiotic products with documented health benefits worldwide. It operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee’s dairy product. The Other segment provides packaging solutions. The company offers its products in the areas of infantile colic; antibiotic-associated and acute diarrhoea; gingivitis; periodontal disease; Helicobacter pylori–the gastric ulcer bacterium; low bone density; and diverticulitis, as well as baby and child gut, adult gut, immune, pregnancy, oral, and bone health. It offers its products under the BioGaia brand name. BioGaia AB (publ) was founded in 1990 and is headquartered in Stockholm, Sweden.

Read More

Analyst Price Target

Average131.50 (+27.92% Upside)
High153.00
Low110.00
Price102.80
No. of Analysts2
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts Consensus

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsStrong SellStrong BuyStrong BuyStrong BuyStrong Buy
SummaryNeutralStrong BuyStrong BuyStrong BuyStrong Buy